Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Caffeine on Cerebrovascular and Retinal Microvessel Reactivity

NCT04730193 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT04730193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Caffeine on Cerebrovascular and Retinal Microvessel Reactivity
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Completed
Start date
February 1, 2021
Completion date
August 1, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine